InsidersTradesSigma
Track the 에스바이오메딕스 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 에스바이오메딕스 has published 2 public disclosures. Market capitalisation: €207.3bn. The latest transaction was filed on 22 April 2026 (Purchase). Among the most active insiders: 타이거자산운용투자일임. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Listed on the XKRX market, 에스바이오메딕스 specializes in the health and pharmaceutical sector. The company focuses on developing innovative medical solutions.